These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37746394)

  • 1. The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients.
    Özdede M; Taban H; Akman O; Önder S; Kılıçkap S
    Cureus; 2023 Aug; 15(8):e44016. PubMed ID: 37746394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.
    Liu YZ; Yang H; Cao J; Jiang YY; Hao JJ; Xu X; Cai Y; Wang MR
    Sci Rep; 2016 Apr; 6():24786. PubMed ID: 27098511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.
    Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y
    J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer.
    Sakabe T; Azumi J; Haruki T; Umekita Y; Nakamura H; Shiota G
    Oncol Lett; 2017 May; 13(5):3703-3708. PubMed ID: 28521472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIAA1522 is a new biomarker of promoting the tumorigenesis and distant metastasis of colorectal carcinoma.
    Yi X; Hu C; Zhang C; Shao K; Sun H; Jiang Y; Sun N; Zhi X
    Cell Signal; 2022 Feb; 90():110202. PubMed ID: 34826587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
    Park SJ; Lee CS; Chung SS
    Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma.
    Xu Y; Sun C; Han B; Xi Y; Zhang M; Yang J; Chen Z
    Oncol Lett; 2020 Jul; 20(1):509-516. PubMed ID: 32565976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
    Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
    J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC.
    Jiang YJ; Zhang TT; Zhu YQ; Cai HQ; Chang C; Hao JJ; Cai Y; Wang MR; Liang JW; Zhang Y
    Transl Oncol; 2023 Feb; 28():101609. PubMed ID: 36571988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity.
    Xie ZH; Yu J; Shang L; Zhu YQ; Hao JJ; Cai Y; Xu X; Zhang Y; Wang MR
    Onco Targets Ther; 2017; 10():3743-3754. PubMed ID: 28794639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.
    Yan J; Wan D
    J Clin Lab Anal; 2022 Feb; 36(2):e24140. PubMed ID: 34952984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
    Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
    He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
    Front Immunol; 2022; 13():835630. PubMed ID: 35401554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.